The Dow Jones Industrial Average (^DJI) was up 305.43 (+0.66%) points today, closing at 46,429.49. Dow Futures (YM=F) also signaled strength, rising 280.00 (+0.60%) points to reach 46,695.00. The primary driver for Wednesday’s market action was a better-than-expected Durable Goods report, which suggested that capital spending remains resilient despite elevated borrowing costs. This economic data sparked a rally in cyclical stocks, as investors gained confidence in a "soft landing" scenario for the U.S. economy. Additionally, positive sentiment in the Healthcare sector provided a secondary boost, as major pharmaceutical firms saw increased buying interest following a series of favorable analyst upgrades.
Within the index, Sherwin-Williams (SHW) emerged as the top performer, climbing 2.51% to $321.66. Other significant gainers included Merck (MRK), which rose 2.40% to $119.14, and Honeywell (HON), which advanced 2.31% to $226.70. The tech and retail sectors also saw notable gains, with Amazon (AMZN) increasing 2.13% to $211.72 and Nvidia (NVDA) jumping 2.05% to $178.815. Furthermore, Johnson & Johnson (JNJ) saw a price increase of 2.11% to $240.23, while Boeing (BA) and Cisco (CSCO) posted gains of 1.79% and 1.70% respectively, reflecting broad optimism across industrial sub-sectors.
Conversely, the market rally was capped by losses in several defensive and tech-heavy components. UnitedHealth Group (UNH) led the decliners, falling 1.00% to $269.53. Cloud and software giant Salesforce (CRM) dropped 0.85% to $181.5775, while Nike (NKE) fell 0.84% to $53.055. Telecommunications and insurance stocks also faced headwinds, with Verizon (VZ) declining 0.80% to $50.4912 and Travelers (TRV) losing 0.75% to close at 290.91. Even Microsoft (MSFT) struggled to find footing, ending the day down 0.68% at $370.30. These losses highlight a selective market where investors are rotating out of high-valuation tech into undervalued industrial and healthcare plays.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.